LENZ Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2022 to Q2 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
LENZ Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q2 2025.
  • LENZ Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2025 was -24.4 %, a 33.5% increase year-over-year.
  • LENZ Therapeutics, Inc. annual Return On Assets for 2024 was -23.2 %, a 22.7% increase from 2023.
  • LENZ Therapeutics, Inc. annual Return On Assets for 2023 was -30 %, a 3.02% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2025 -24.4 +12.3 +33.5% Apr 1, 2025 Jun 30, 2025
Q1 2025 -22.7 +12.5 +35.6% Jan 1, 2025 Mar 31, 2025
Q4 2024 -23.2 +6.81 +22.7% Oct 1, 2024 Dec 31, 2024
Q3 2024 -34.1 -10.1 -42.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -36.7 -12.3 -50.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -35.2 -8.55 -32.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30 -0.88 -3.02% Oct 1, 2023 Dec 31, 2023
Q3 2023 -23.9 +2.05 +7.89% Jul 1, 2023 Sep 30, 2023
Q2 2023 -24.5 -2.46 -11.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -26.6 -7.2 -37.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -29.1 Oct 1, 2022 Dec 31, 2022
Q3 2022 -26 Jul 1, 2022 Sep 30, 2022
Q2 2022 -22 Apr 1, 2022 Jun 30, 2022
Q1 2022 -19.4 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.